During the past decade, Virginia Mason Cancer Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 6 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Virginia Mason Cancer Center" #1 sponsor was "Celgene" with 3 trials, followed by "Novartis Pharmaceuticals" with 2 trials sponsored, "Radiation Therapy Oncology Group" with 2 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored and "Gilead Sciences" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Virginia Mason Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Radiation Therapy Oncology Group" with 2 trials as a collaborator, "Danish Head and Neck Cancer Group" with 1 trials as a collaborator, "Eastern Cooperative Oncology Group" with 1 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Virginia Mason Cancer Center" are "Breast Cancer" (3 trials), "Adenocarcinoma" (1 trials), "Advanced Breast Cancer" (1 trials), "Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors" (1 trials) and "Antimetabolites, Antineoplastic" (1 trials). Many other conditions were trialed in "Virginia Mason Cancer Center" in a lesser frequency.

Most popular intervention types in "Virginia Mason Cancer Center" are "Drug" (10 trials), "Radiation" (3 trials), "Dietary Supplement" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ribociclib" (2 trials), "nab-paclitaxel" (2 trials), "radiation therapy" (2 trials), "5FU" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Virginia Mason Cancer Center" are 9 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Virginia Mason Cancer Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Virginia Mason Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Virginia Mason Cancer Center, 3 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".